Botanix Pharmaceuticals

We are moving quickly, but never at the expense of our rigorous commitment to ethical research and development, and the highest clinical standards mandated by the US Food and Drug Administration (FDA). We have a lean, multidisciplinary team, committed and empowered to work at the highest industry standards. Mr Ippolito is a leading pharmaceutical expert who has over 30 years of experience in the industry, including more than 20 years in dermatology. Ippolito was Executive Vice President and Chief Commercial Officer at Medicis, an industry leading dermatology and aesthetic company. Mr Matt Callahan is the founding executive director of Botanix. Dr Stewart Washer is a respected senior executive with more than 20 years of experience at Board and senior executive levels across medical technology, biotechnology and agrifood companies. Previously, Dr Washer has been an Investment Director at Bioscience Managers, a leading life science investment firm and was a Venture Partner with the Swiss Inventages Fund, a €1.5bn life science fund, funded by Nestle. Dr Bill Bosch is a seasoned pharmaceutical executive with more than 20 years of experience in the industry, focusing on applications of nanotechnology to drug product development.